Research Projects & Grants

For Profit Organization

  • Compassionate use of thyrogen, Role: PI, Genzyme Corporation, (06/1998 - 05/1999) Status: Completed
  • DuP 843-048-036 A multicenter trial to characterize lesions which were not detected by physical examination or mammography, but which were identified by technetium Tc99m Sestamibi Scintigraphic Images of DuP 8343-045 subjects, Role: PI, DuPont Merck Pharmaceutical Company, (08/1997 - 08/1998) Status: Completed
  • ViRx. A phase I multiple dose, tolerance and pharmacokinetic trial of CI-1012, Role: PI, viRx Incorporated (Park Davis), (08/1997 - 08/1998) Status: Completed
  • A Blinded, Multicenter, Clinical Study Assessing the Safety and Efficacy of Indium in 111 Pentetreotide for Staging Patients Before and After Chemotherapy for Small Cell Lung Cancer, Role: Investigator, Mallinckrodt Medical Inc., (09/1996 - 09/1997) Status: Completed
  • An Open-Label Multicenter Trial to Evaluate the Diagnostic Accuracy of Technetium Tc99m-Sestamibi Scintigraphic Images in Identifying Malignant Breast Lesions, in Subjects with Breast Abnormalities Detected by Palpation, Role: PI, DePont Merck, (07/1994 - 07/1995) Status: Completed
  • QuadrametTM study 303521 double-blind placebo-controlled study of Samarium Sm-153 lexidronam (QuadrametTM) for the treatment of asymptomatic skeletal metastases in patients with hormone-refractory prostate carcinoma, Role: Investigator, Berlex Laboratories Inc., Status: Completed

Internal

  • An Open-Label Multicenter Trial to Evaluate the Diagnostic Accuracy of Technetium Tc99m-Sestamibi Scintigraphic Images in Identifying Malignant Breast Lesions, in Subjects with Mammographically Detected Non-palpable Breast Abnormalities, Role: PI, LLU Dept. of Radiation Sciences, (07/1994 - 07/1995) Status: Completed

Other Research

  • Cerebral Perfusion Changes 20 Polycythemia in Physchiatric Change ie Depression (Present - 2001)
  • Evaluation of hip mineral content to predict risk of fracture; Schulz E, Libanati C, Kirk G, Baylind D (1985 - 1991)
  • Spinal bone mass by dual-photon absorptionmetry in bone metabolism disorders, comparison with spinal density measured by computed tomography;  Schulz E, Libanati C, Kirk G, Baylind D (1984 - 1991)
  • Determination of left ventricular volumes with correction of soft tissue attenuation by evaluation of the scatter spectrum; Schulz E, Kirk G, Davidson, D (1983 - 1991)
  • Clinical Evaluation (phase III) of Anti CEA Monoclonal Antibody ZCE025 IVP Hybritech, Inc. (1989 - 1990)
  • Bone metabolism determination using retention curves of a bone scanning agent; Schulz E, Kirk G (1982 - 1990)
  • Scintigraphy in fluoride treated osteoporotic and comparison with other methods; (1982 - 1987)
  • Method to evaluation left ventricular volumes with scintigraphy utilizing a phantom; BSR grant, $1,500, Schulz EE, Kirk G, Davidson D (Present - 1983)
  • Indium-111 Platelet Survival (Present - 1981)
  • Evaluation of radioisotopic first pass ejection fraction with a heart model; Basic Research Grant, LLU School of Medicine (Present - 1980)